← All trials
NCT05543343
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 5, 2022
- Primary completion
- Mar 31, 2023
- Completion date
- Aug 31, 2023
- First posted
- Sep 16, 2022
- Last posted
- Sep 16, 2022
- Enrollment
- 495
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shandong UniversityLead sponsor
- Qilu Pharmaceutical Co., Ltd.Collaborator
- Shandong UniversitySponsor investigator
- Shandong UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.